Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Toxicology ; 394: 54-62, 2018 02 01.
Article de Anglais | MEDLINE | ID: mdl-29253600

RÉSUMÉ

Cadmium, an environmental neurotoxic compound, produces cognitive disorders, although the mechanism remains unknown. Previously, we described that cadmium induces a more pronounced cell death on cholinergic neurons from basal forebrain (BF). This effect, partially mediated by M1 receptor blockade, triggering it through AChE splices variants alteration, may explain cadmium effects on learning and memory processes. Cadmium has been also reported to induce oxidative stress generation leading to M2 and M4 muscarinic receptors alteration, in hippocampus and frontal cortex, which are necessary to maintain cell viability and cognitive regulation, so their alteration in BF could also mediate this effect. Moreover, it has been reported that antioxidant treatment could reverse cognitive disorders, muscarinic receptor and AChE variants alterations induced by cadmium. Thus, we hypothesized that cadmium induced cell death of BF cholinergic neurons is mediated by oxidative stress generation and this mechanism could produce this effect, in part, through AChE variants altered by muscarinic receptors disruption. To prove this, we evaluated in BF SN56 cholinergic neurons, whether cadmium induces oxidative stress and alters muscarinic receptors, and their involvement in the induction of cell death through alteration of AChE variants. Our results show that cadmium induces oxidative stress, which mediates partially the alteration of AChE variants and M2 to M4 muscarinic receptors expression and blockage of M1 receptor. In addition, cadmium induced oxidative stress generation by M1 and M3 receptors alteration through AChE variants disruption, leading to cell death. These results provide new understanding of the mechanisms contributing to cadmium harmful effects on cholinergic neurons.


Sujet(s)
Acetylcholinesterase/métabolisme , Chlorure de cadmium/toxicité , Neurones cholinergiques/effets des médicaments et des substances chimiques , Espèces réactives de l'oxygène/métabolisme , Récepteur muscarinique de type M1/métabolisme , Récepteur muscarinique de type M2/métabolisme , Animaux , Lignée cellulaire , Survie cellulaire/effets des médicaments et des substances chimiques , Neurones cholinergiques/métabolisme , Neurones cholinergiques/anatomopathologie , Peroxydation lipidique/effets des médicaments et des substances chimiques , Mémoire/effets des médicaments et des substances chimiques , Souris , Maladies neurodégénératives/induit chimiquement , Maladies neurodégénératives/métabolisme , Maladies neurodégénératives/anatomopathologie , Stress oxydatif/effets des médicaments et des substances chimiques , Prosencéphale/effets des médicaments et des substances chimiques , Prosencéphale/métabolisme , Prosencéphale/anatomopathologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE